Cofinimmo (COFB) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
22 Apr, 2026Executive summary
Net result from core activities (EPRA Earnings, excluding non-recurring effects) rose 8.3% year-over-year to €62 million, outperforming outlook due to positive contract indexation and cost evolution.
Net result (Group share) was €54 million, down from €64 million year-over-year due to non-recurring effects from the Aedifica combination.
Gross rental income reached €89 million, up 0.7% year-over-year and 1.1% like-for-like; occupancy rate at 98.5%.
Residual lease length remains long at 12 years; portfolio valued at €6.1 billion, 77% in healthcare real estate.
Aedifica now holds 80% of capital; combination effective since 10.03.2026, with integration and merger expected in H2 2026.
Financial highlights
Net result from core activities – Group share: €62 million (+8.3% YoY); EPRA EPS: €1.63/share.
Net result – Group share: €54 million (€1.41/share), impacted by €11 million non-recurring expense from Aedifica combination.
Gross rental income: €89 million (+1.1% like-for-like); operating margin at 86.5%.
Debt-to-assets ratio: 42.1%; average cost of debt: 1.5%.
EPRA NRV per share: €102.40; EPRA NTA per share: €93.98; IFRS NAV per share: €93.60.
Outlook and guidance
2026 net result from core activities (EPRA EPS) expected at €6.35/share; gross dividend guidance at €5.20/share (82% payout).
Net investments for 2026 estimated at €200 million (gross investments €310 million, divestments €110 million).
Average cost of debt expected to rise slightly to 1.7%; debt-to-assets ratio projected at 44%.
Latest events from Cofinimmo
- 2025 outperformed outlook with robust earnings, high occupancy, and healthcare focus.COFB
Q4 202511 Apr 2026 - Healthcare assets drive 4% earnings growth and 2024 guidance confirmation.COFB
Q2 20242 Feb 2026 - 2024 results beat expectations with a healthcare-focused portfolio and strong financials.COFB
Q4 202416 Dec 2025 - Core earnings up 2% to €186M, 98.6% occupancy, 2025 EPS ≥€6.20/share confirmed.COFB
Q3 202524 Oct 2025 - Core earnings up 2.4%, 98.6% occupancy, 2025 EPS ≥€6.20, dividend €5.20.COFB
Q2 202525 Jul 2025 - Q3 2024 results show robust growth, high occupancy, and strong guidance for EPS and dividend.COFB
Q3 202413 Jun 2025 - Core earnings up 5% in Q1 2025, driven by healthcare and strong occupancy.COFB
Q1 20256 Jun 2025